{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:16:13Z","timestamp":1780492573996,"version":"3.54.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cld.2024.01.007","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T21:03:03Z","timestamp":1708030983000},"page":"297-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nontraditional Treatment of Hepatic Encephalopathy"],"prefix":"10.1016","volume":"28","author":[{"given":"Jasleen","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven-Huy","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2024.01.007_bib1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.05.042","article-title":"European Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases","volume":"61","year":"2014","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2024.01.007_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy","volume":"77","year":"2022","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2024.01.007_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40265-018-1017-0","article-title":"Hepatic Encephalopathy in cirrhosis: Pathology and pathophysiology","volume":"79","author":"Butterworth","year":"2019","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.cld.2024.01.007_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cld.445","article-title":"Pathophysiological mechanisms of hepatic encephalopathy","volume":"5","author":"Tranah","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2024.01.007_bib5","doi-asserted-by":"crossref","first-page":"748253","DOI":"10.3389\/fcell.2021.748253","article-title":"Gut Microbes and hepatic encephalopathy: From the old Concepts to new perspectives","volume":"9","author":"Rocco","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.cld.2024.01.007_bib6","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jhep.2020.07.013","article-title":"Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy","volume":"73","author":"Rose","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2024.01.007_bib7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4254\/wjh.v14.i4.670","article-title":"Evidence-based approach to management of hepatic encephalopathy in adults","volume":"14","author":"Hoilat","year":"2022","journal-title":"World J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2024.01.007_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4161\/gmic.28684","article-title":"The role of microbiota in hepatic encephalopathy","volume":"5","author":"Bajaj","year":"2014","journal-title":"Gut Microb"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2024.01.007_bib9","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.jceh.2014.06.005","article-title":"Diagnosis of minimal hepatic encephalopathy","volume":"5","author":"Weissenborn","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"17","key":"10.1016\/j.cld.2024.01.007_bib10","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMra1600561","article-title":"Hepatic encephalopathy","volume":"375","author":"Wijdicks","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2024.01.007_bib11","first-page":"142","article-title":"Hepatic encephalopathy: an Update on the Pathophysiology and therapeutic options","volume":"5","author":"Elwir","year":"2017","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"18","key":"10.1016\/j.cld.2024.01.007_bib12","first-page":"4050","article-title":"New Therapies of liver diseases: hepatic encephalopathy","volume":"10","author":"Mangini","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"12","key":"10.1016\/j.cld.2024.01.007_bib13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2024.01.007_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/DDDT.S172324","article-title":"Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy","volume":"13","author":"Wang","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"10.1016\/j.cld.2024.01.007_bib15","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.01.007_bib16","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2024.01.007_bib17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.mayocp.2015.03.003","article-title":"Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy","volume":"90","author":"Tapper","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.cld.2024.01.007_bib18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/microorganisms3040759","article-title":"Gut Microbiota and host Reaction in liver diseases","volume":"3","author":"Fukui","year":"2015","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.cld.2024.01.007_bib19","doi-asserted-by":"crossref","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","article-title":"Linkage of gut microbiome with cognition in hepatic encephalopathy","volume":"302","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cld.2024.01.007_bib20","doi-asserted-by":"crossref","first-page":"100333","DOI":"10.1016\/j.aohep.2021.100333","article-title":"Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy","volume":"25","author":"Bloom","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2024.01.007_bib21","doi-asserted-by":"crossref","first-page":"26800","DOI":"10.1038\/srep26800","article-title":"Impaired gut-liver-brain Axis in Patients with cirrhosis","volume":"6","author":"Ahluwalia","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.cld.2024.01.007_bib22","first-page":"7577","article-title":"Probiotics, prebiotics and synbiotics- a review","volume":"52","author":"Pandey","year":"2015","journal-title":"J\u00a0Food Sci Technol"},{"issue":"8","key":"10.1016\/j.cld.2024.01.007_bib23","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.12998\/wjcc.v8.i8.1361","article-title":"Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases","volume":"8","author":"Cheng","year":"2020","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.cld.2024.01.007_bib24","doi-asserted-by":"crossref","first-page":"480309","DOI":"10.1155\/2012\/480309","article-title":"A\u00a0current review of the diagnostic and treatment strategies of hepatic encephalopathy","volume":"2012","author":"Poh","year":"2012","journal-title":"Int J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.01.007_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00253-021-11646-8","article-title":"Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics","volume":"106","author":"Yadav","year":"2022","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6","key":"10.1016\/j.cld.2024.01.007_bib26","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2013.11.006","article-title":"Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial","volume":"12","author":"Lunia","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2024.01.007_bib27","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1572-0241.2008.01861.x","article-title":"Probiotic yogurt for the treatment of minimal hepatic encephalopathy","volume":"103","author":"Bajaj","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2024.01.007_bib28","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/liv.13005","article-title":"Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials","volume":"36","author":"Saab","year":"2016","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2024.01.007_bib29","first-page":"CD008716","article-title":"Probiotics for people with hepatic encephalopathy","volume":"2","author":"Dalal","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.cld.2024.01.007_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.hbpd.2018.01.005","article-title":"Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: a meta-analysis","volume":"17","author":"Cao","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"4","key":"10.1016\/j.cld.2024.01.007_bib31","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2019.08.047","article-title":"Comparative Efficacy of treatment Options for minimal hepatic encephalopathy: a systematic Review and network meta-analysis","volume":"18","author":"Dhiman","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2024.01.007_bib32","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2024.01.007_bib33","doi-asserted-by":"crossref","first-page":"e0210016","DOI":"10.1371\/journal.pone.0210016","article-title":"Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis","volume":"14","author":"Hui","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2024.01.007_bib34","doi-asserted-by":"crossref","first-page":"779205","DOI":"10.3389\/fmed.2022.779205","article-title":"A\u00a0randomized placebo-controlled Trial of combination therapy with post-triple-antibiotic-therapy fecal microbiota Transplantation and Alginate for ulcerative colitis: protocol","volume":"9","author":"Ishikawa","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.cld.2024.01.007_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","article-title":"Findings From a randomized controlled Trial of fecal Transplantation for patients with ulcerative colitis","volume":"149","author":"Rossen","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2024.01.007_bib36","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/00365521.2021.1899277","article-title":"Fecal microbiota transplantation in hepatic encephalopathy: a systematic review","volume":"56","author":"Madsen","year":"2021","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2024.01.007_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5946\/ce.2019.009","article-title":"Fecal microbiota transplantation: an Update on clinical practice","volume":"52","author":"Kim","year":"2019","journal-title":"Clin Endosc"},{"issue":"6","key":"10.1016\/j.cld.2024.01.007_bib38","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2024.01.007_bib39","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1053\/j.gastro.2019.01.033","article-title":"Long-term Outcomes of fecal microbiota Transplantation in patients with cirrhosis","volume":"156","author":"Bajaj","year":"2019","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2024.01.007_bib40","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are Safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2024.01.007_bib41","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/hep4.1950","article-title":"Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient","volume":"6","author":"Bloom","year":"2022","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.cld.2024.01.007_bib42","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jceh.2018.06.004","article-title":"The role of branched chain amino Acids in the treatment of hepatic encephalopathy","volume":"8","author":"Dam","year":"2018","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2024.01.007_bib43","first-page":"CD001939","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","volume":"5","author":"Gluud","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.cld.2024.01.007_bib44","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/ajg.2011.9","article-title":"Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study","volume":"106","author":"Les","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2024.01.007_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40265-018-1024-1","article-title":"L-ornithine L-aspartate (LOLA) for hepatic Encephalopathy in cirrhosis: Results of randomized controlled Trials and meta-analyses","volume":"79","author":"Butterworth","year":"2019","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.cld.2024.01.007_bib46","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.32255","article-title":"L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: a double-blind randomized controlled trial","volume":"75","author":"Jain","year":"2022","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2024.01.007_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40265-018-1023-2","article-title":"Pharmacokinetic and pharmacodynamic Properties of L-ornithine L-aspartate (LOLA) in hepatic encephalopathy","volume":"79","author":"Kircheis","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.cld.2024.01.007_bib48","article-title":"L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis","volume":"5","author":"Goh","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.cld.2024.01.007_bib49","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/hep.23589","article-title":"Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis","volume":"51","author":"McGuire","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2024.01.007_bib50","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/hep.26611","article-title":"Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy","volume":"59","author":"Rockey","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2024.01.007_bib51","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/cpdd.18","article-title":"Glycerol Phenylbutyrate in patients with Cirrhosis and episodic hepatic encephalopathy: a pilot Study of Safety and Effect on venous ammonia concentration","volume":"2","author":"Ghabril","year":"2013","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"2","key":"10.1016\/j.cld.2024.01.007_bib52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/fcp.12340","article-title":"Brain-Liver Piti\u00e9-Salp\u00eatri\u00e8re Study Group (BLIPS). Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study","volume":"32","author":"Weiss","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.cld.2024.01.007_bib53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5604\/16652681.1184191","article-title":"The role of zinc in liver cirrhosis","volume":"15","author":"Gr\u00fcngreiff","year":"2016","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.01.007_bib54","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/hepr.13601","article-title":"Zinc deficiency predicts overt hepatic encephalopathy and mortality in liver cirrhosis patients with minimal hepatic encephalopathy","volume":"51","author":"Miwa","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cld.2024.01.007_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2019.11.009","article-title":"Zinc and protein metabolism in chronic liver diseases","volume":"74","author":"Katayama","year":"2020","journal-title":"Nutr Res"},{"key":"10.1016\/j.cld.2024.01.007_bib56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1475-2891-12-74","article-title":"A\u00a0systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy","volume":"12","author":"Chavez-Tapia","year":"2013","journal-title":"Nutr J"},{"issue":"4","key":"10.1016\/j.cld.2024.01.007_bib57","first-page":"219","article-title":"Sodium benzoate for treatment of hepatic encephalopathy","volume":"9","author":"Misel","year":"2013","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.01.007_bib58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.1840160123","article-title":"Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial","volume":"16","author":"Sushma","year":"1992","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2024.01.007_bib59","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MPG.0000000000002521","article-title":"Efficacy and Safety of sodium Benzoate in the Management of Hyperammonemia in decompensated chronic liver Disease of the childhood-A double-blind randomized controlled trial","volume":"70","author":"Snehavardhan","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cld.2024.01.007_bib60","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819879565","article-title":"Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity","volume":"12","author":"Ba\u00f1ares","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2024.01.007_bib61","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/cc4825","article-title":"The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure","volume":"10","author":"Saliba","year":"2006","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.cld.2024.01.007_bib62","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.21930","article-title":"Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis","volume":"46","author":"Hassanein","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2024.01.007_bib63","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Ba\u00f1ares","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.01.007_bib64","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0168-8278(99)80144-5","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis","volume":"30","author":"Bustamante","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.01.007_bib65","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/lt.24440","article-title":"Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy","volume":"22","author":"Lynn","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2024.01.007_bib66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/HMER.S169024","article-title":"Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options","volume":"11","author":"Philips","year":"2019","journal-title":"Hepat Med"},{"issue":"4","key":"10.1016\/j.cld.2024.01.007_bib67","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1499-3872(14)60280-0","article-title":"Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials","volume":"13","author":"Xu","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"6","key":"10.1016\/j.cld.2024.01.007_bib68","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.clinre.2015.03.008","article-title":"Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis","volume":"39","author":"Zhao","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2024.01.007_bib69","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1872-034X.2012.01015.x","article-title":"Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy","volume":"42","author":"Holte","year":"2012","journal-title":"Hepatol Res"},{"issue":"6","key":"10.1016\/j.cld.2024.01.007_bib70","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2036.2010.04574.x","article-title":"Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy","volume":"33","author":"Shukla","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.cld.2024.01.007_bib71","first-page":"CD008716","article-title":"Probiotics for patients with hepatic encephalopathy","author":"McGee","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"51","key":"10.1016\/j.cld.2024.01.007_bib72","doi-asserted-by":"crossref","first-page":"e32335","DOI":"10.1097\/MD.0000000000032335","article-title":"Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"101","author":"Huang","year":"2022","journal-title":"Medicine (Baltim)"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T05:41:42Z","timestamp":1711518102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326124000072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1089326124000072"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2024.01.007","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nontraditional Treatment of Hepatic Encephalopathy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2024.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}